Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Early Secondary Prevention of PTSD in Women Victims of Sexual Violence
NCT07452978Phase 2Not yet recruiting
- Sponsor
- University Hospital Tours
- Start
- Sep 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Propranolol with Placebo (2 arms). Primary endpoint: Participant rate with post-traumatic stress disorder symptoms at 5 weeks. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
propranolol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT07452978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07452978.